The c-erbB3/HER3 receptor in human cancer

Cancer Surveys

Volumn 27, Issue , 1996, Pages 339-349

  Gullick, W J ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ONCOPROTEIN; PROTEIN TYROSINE KINASE;

CANCER; GENE SEQUENCE; MOLECULAR CLONING; ONCOGENE C ERB; ONCOGENE NEU; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

ANIMALS; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-3;

EID: 0029987320     PISSN: 02612429     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Alimandi M, Romano A, Curia MC et al (1995) Cooperative signaling of ErbBS and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene 10 1813-1821
2. Ben-Baruch N and Yarden Y (1994) Neu differentiation factors: a family of alternatively spliced neuronal and mesenchymal factors. Proceedings of the Society for Experimental Biology and Medicine 206 221-227
3. Carraway KL, Sliwkowski MX, Akita R et al (1994) The erbB3 gene product is a receptor for heregulin. Journal of Biological Chemistry 269 14303-14306
4. Carraway KL, Soltoff SP, Diamonti AJ and Cantley LC (1995) Heregulin stimulates mitogenesis and phosphatidylinositol 3-kinase in mouse fibroblasts transfected with erbB2/neu and erbB3. Journal of Biological Chemistry 270 7111-7116
5. Fedi P, Pierce JH, Di Fiore PP and Kraus MH (1994) Efficient coupling with phosphatidylinositol 3-kinase, but not phospholipase cγ or GTPase-activating protein, distinguishes ErbB-3 signaling from that of other ErbB/EGFR family members. Molecular and Cellular Biology 14 492-500
6. Friess H, Yamanaka Y, Kobrin MS, Do DA, Buchler MW and Korc M (1995) Enhanced erbB-3 expression in human pancreatic cancer correlates with tumour progression. Clinical Cancer Research 1 1413-1420
7. Gasparini G, Gullick WJ, Maluta S et al (1994) c-erbB-3 and c-erbB-2 protein expression in node negative breast carcinoma, an immunocytochemical study. European Journal of Cancer 30A 16-22
8. Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway KL (1994) Insect cell-expressed p180 erbB3 possesses an impaired tyrosine kinase activity. Proceedings of the National Academy of Sciences of the USA 91 8132-8136
9. Hack N, Sueaquan A, Mills CB and Skorecki KL (1993) Expression of human tyrosine kinase negative epidermal growth factor receptor amplifies signaling through endogenous murine epidermal growth factor receptor. Journal of Biological Chemistry 268 26441-26446
10. Hellyer NJ, Kim HH, Greaves CH, Sierke SL and Koland JG (1995) Molecular cloning of the rat erbB3 cDNA and characterization of the gene product. FASEB Journal 9 A1414
11. Hollywood DP and Hurst HC (1993) A novel transcription factor, OB2-1, is required for overexpression of the protooncogene c-erbB-2 in mammary tumour lines. EMBO Journal 12 2369-2375
12. Holmes WE, Sliwkowski MX, Akita RW et al (1992) Identification of heregulin a specific activator of p185erbB2. Science 256 1205-1210
13. Hunt CR, Hale RJ, Armstrong C, Rajkumar T, Gullick WJ and Buckley CH (1995) c-erbB-3 proto-oncogene expression in uterine cervical carcinoma. International Journal Gynecological Cancer 5 282-285
14. Issing WJ, Heppt WJ and Kastenbauer ER (1993) erbB-3, a third member of the erbB/ epidermal growth factor receptor gene family: its expression in head and neck cancer cell lines. European Archives of Otorhinolaryngology 250 392-395
15. Jeschke M, Weis W, Dengler W, Imber R, Stocklin E and Groner B (1995) Targeted inhibition of tumour-cell growth by recombinant heregulin-toxin fusion proteins. International Journal of Cancer 60 730-739
16. Katoh M, Yazaki Y, Sugimura T and Terada M (1993) c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase. Biochemical and Biophysical Research Communications 192 1189-1197
17. Kim HH, Sierke SL and Koland JG (1994) Epidermal growth factor-dependent association of phosphatidylinositol 3-kinase with erbB3 gene product. Journal of Biological Chemistry 40 24747-24755
18. Kita YA, Barff J, Luo Y et al (1994) NDF/heregulin stimulates the phosphorylation of Her3/erbB3. FEBS Letters 349 139-143
19. Kraus MH, Issing W, Mild T, Popescu NC and Aaronson SA (1989) Isolation and characterization of ErbB3, a third member of the erbB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proceedings of the National Academy of Sciences of the USA 86 9193-9197
20. Kraus MH, Fedi P, Starks V, Muraro R and Aaronson SA (1993) Demonstration of Iigand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast-tumor cells. Proceedings of the National Academy of Sciences of the USA 90 2900-2904
21. Lemoine NR, Barnes DM, Hollywood DP et al (1992a) Expression of the erbBS gene product in breast cancer. British Journal of Cancer 66 1116-1121
22. Lemoine NR, Lobresco M, Leung H et al (1992b) The erbB-3 gene in human pancreatic cancer. Journal of Pathology 168 269-273
23. Lu HS, Chang D, Philo JS et al (1995) Studies on the structure and function of glycosylated and nonglycosylated neu differentiation factors. Journal of Biological Chemistry 270 4784-4791
24. Mandai M, Konishi I, Koshiyama M et al (1994) Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. Cancer Research 54 1825-1830
25. Marchionni MA, Goodearl ADJ, Chen MS et al (1993) Glial growth factors are alternatively spliced erbB2 ligands expressed in the nervous system. Nature 362 312-318
26. Marikovsky M, Lavi S, Pinkas-Kramarski R et al (1995) ErbB-3 mediates differential mitogenic effects of NDF/heregulin isoforms on mouse keratinocytes. Oncogene 10 1403-1411
27. Marte BM, Jeschke M, Graus-Porta D et al (1995) Neu differentiation factor/heregulin modulates growth and differentiation of HCI1 mammary epithelial cells. Molecular Endocrinology 9 14-23
28. Moran MF, Koch CA, Sadowski I and Pawson T (1988) Mutational analysis of a phosphotransfer motif essential for v-fps tyrosine kinase activity. Oncogene 3 665-672
29. Morrissey TK, Levi ADO, Nuijens A, Sliwkowski MX and Bunge RP (1995) Axon-induced mitogenesis of human Schwann cells involves heregulin and p185 erbB2. Proceedings of the National Academy of Sciences of the USA 92 1431-1435
30. Myers RB, Srivastava S, Oelschlager DK and Grizzle WE (1994) Expression of p160 erbB-3 and p185 erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Journal of the National Cancer Institute 86 1140-1145
31. Pinkas-Kramarski R, Eilam R, Spiegler O et al (1994) Brain neurons and glial cells express neu differentiation factor/heregulin: a survival factor for astrocytes. Proceedings of the National Academy of Sciences of the USA 91 9387-9391
32. Plowman GD, Whitney GS, Neubauer MG et al (1990) Molecular cloning and expression of an additional epidermal growth factor receptor-related gene. Proceedings of the National Academy of Sciences of the USA 87 4905-4909
33. Plowman GD, Culouscou JM, Whitney GS et al (1993a) Ligand-specific activation of HER4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proceedings of the National Academy of Sciences of the USA 90 1746-1750
34. Plowman GD, Green JM, Culouscou JM et al (1993b) Heregulin induces tyrosine phosphoyrlation of HER4/p180erbB4. Nature 366 473-475
35. Poller DN, Spendlove I, Baker C et al (1992) Production and characterization of a polyclonal antibody to the c-erbB-3 protein: examination of c-erbB-3 protein expression in adenocarcinomas. 168 275-280
36. Prigent SA and Gullick WJ (1994) Identification of c-erbB-3 binding sites for phosphatidylinositol 3′ -kinase and SHC using an EGF receptor/c-erbB-3 chimera. EMBO Journal 13 2831-2841
37. Prigent SA, Lemoine NR, Hughes CM, Plowman GD, Selden C and Gullick WJ (1992) Expression of the c-erbB-3 protein in normal human adult and fetal tissues. Oncogene 7 1273-1278
38. Prigent SA, Pillay TS, Ravichandrani KS and Gullick WJ (1995) Binding of she to the NPXY motif is mediated by its N-terminal domain. Journal of Biological Chemistry 270 22097-22100
39. Quinn CM, Ostrowski JL, Lane SA, Loney DP, Teasdale J and Benson EA (1994) c-erbB-3 protein expression in human breast cancer: comparison with other tumour variables and survival. Histopathology 25 247-252
40. Rajkumar T and Gullick WJ (1994) A monoclonal antibody to the human c-erbB-3 protein stimulates the anchorage-independent growth of breast cancer cell lines. British Journal of Cancer 70 459-465
41. Rajkumar T, Gooden CSR, Lemoine NR and Gullick WJ (1993) Expression of the c-erbB-3 protein in gastrointestinal tract tumours determined by monoclonal antibody RTJ1. Journal of Pathology 170 271-278
42. Rajkumar T, Hollywood DP, Hurst HC and Gullick WJ (1995a) c-erbB-3 expression in breast tumour derived cell lines. The Breast 4 84-91
43. Rajkumar T, Majhi U, Malligarjuna, Shantha V and Gullick WJ (1995b) Prevalence of c-erbB3 expression in squamous cell carcinomas of the cervix as determined by the monoclonal antibody RTJ2. International Journal of Oncology 6 105-109
44. Ram RG, Kokeny KR, Dilts CA and Ethier SP (1995) Mitogenic activity of neu differentiation factor/heregulin mimics that of epidermal growth factor and insulin-like growth factor-1 in human mammary epithelial cells. Journal of Cellular Physiology 163 589-596
45. Reifenberger G, Reifenberger J, Ichimura K, Meltzer PS and Collins VP (1994) Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Research 54 4299-4303
46. Riese DJ, van Raaij TM, Plowman GD, Andrews GC and Stern DF (1995) The cellular response to neuregulins is governed by complex interactions of the erbB receptor family. Molecular and Cellular Biology 15 5770-5776
47. Sanidas EE, Filipe MI, Linehan J et al (1993) Expression of the c-erbB-3 gene product in gastric cancer. International Journal of Cancer 54 935-940
48. Shah NM, Marchionni MA, Isaacs I, Stroobant P and Anderson DJ (1994) Glial growth factor restricts mammalian neural crest stem cells to a glial fate. Cell 77 349-360
49. Simpson BJB, Weatherill J, Miller EP, Lessells AM, Langdon SP and Miller WR (1995) c-erbB-3 protein expression in ovarian tumours. British Journal of Cancer 71 758-762
50. Skinner A and Hurst HC (1993) Transcriptional regulation of the c-erbB-3 gene in human breast carcinoma cell lines. Oncogene 8 3393-3401
51. Sliwkowski MX, Schaefer G, Akita RW et al (1994) Coexpression of erbB2 and erbB3 proteins reconstitutes a high affinity receptor for heregulin. Journal of Biological Chemistry 269 14661-14665
52. Soler C, Alvarez CV, Beguinot L and Carpenter G (1994) Potent SHC tyrosine phosphorylation by epidermal growth factor at low receptor density or in the absence of receptor autophosphorylation sites. Oncogene 9 2207-2215
53. Soltoff SP, Carraway KL, Prigent SA, Gullick WJ and Cantley LC (1994) ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor. Molecular and Cellular Biology 14 3550-3558
54. Sternberg MJE and Gullick WJ (1990) A sequence motif in the transmembrane region of growth factor receptors with tyrosine kinase activity mediates dimerisation. Protein Engineering 3 245-248
55. 42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247 209-212
56. Ward CW, Hoyne PA and Flegg RH (1995) Insulin and epidermal growth factor receptors contain the cysteine repeat motif found in the tumour necrosis factor receptor. Proteins 22 141-153
57. Wen D, Peles E, Cupples R et al (1992) Neu differentiation factor: a transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69 559-572
58. Wen D, Suggs SV, Karunagaran D et al (1994) Structual and functional aspects of the multiplicity of neu differentiation factors. Molecular and Cellular Biology 14 1909-1919
59. Zimonjic DB, Rezanka J, DiPaolo JA and Popescu NC (1995) Refined localization of the erbB-3 proto-oncogene by direct visualization of FISH signals on LUT-inverted and contrastenhanced digital images and DAPI-banded chromosomes. Cancer Genetics and Cytogenetics 80 100-102